you are here:
Success
Alert
Please select a Day.
Info
106.80
1.05 (0.99%)

As on 13 Apr, 2021 | 03:51

Trade
Day Range
101.95
114.80
L H
52 Week Range
78.60
139.00
L H
Volume
96,982
*
i

* BSE Market Depth (13 Apr 2021)

BUY SELL
QTY PRICE PRICE QTY
125 105.60 109.00 35
45 105.20 109.60 132
53 105.00 110.50 100
101 104.00 110.70 20
50 103.20 114.00 156
962 Total Total 1064
Bid / Ask
105.00 / 108.10
108.10
2.35 (2.22%)

As on 13 Apr, 2021 | 04:00

Day Range
100.40
114.40
L H
52 Week Range
78.25
138.50
L H
Volume
7,373
*
i

* BSE Market Depth (13 Apr 2021)

BUY SELL
QTY PRICE PRICE QTY
125 105.60 109.00 35
45 105.20 109.60 132
53 105.00 110.50 100
101 104.00 110.70 20
50 103.20 114.00 156
962 Total Total 1064
Bid / Ask
105.00 / 108.10
NSE

#KnowBeforeYouInvest

Note :Financial Information is based on consolidated numbers.
Note :Financial Information is based on consolidated numbers.
Note :Financial Information is based on consolidated numbers.
Note :Financial Information is based on consolidated numbers.
Financials
    Ownerships
      Industry Comparison
        Others
          Open103.60
          Previous Close105.75
          UC Limit116.30
          LC Limit95.20
          Volume96,982.00
          VWAP108.66
          Mkt Cap (Rs. Cr.)165
          20D Avg Volume55,579
          20D Avg Delivery22,105
          Beta0.600.64
          Face Value10.00
          TTM EPS1.11
          TTM PE96.22
          Sector PE40.28
          Book Value Per Share77.02
          P/B1.39
          Dividend Yield0.00
          P/C44.50

          Advance Chart

          Click here to expand

          *Refresh in 20 seconds.

          MC Insights

          Mid range performer: Stock with medium financial performance with average price momentum and valuation. These stocks may be affordable and are showing some investors interest.

          Price
          • Bullish Momentum - Above Short, Medium and Long Term Moving Averages
          • 36.49% away from 52 week low
          • 23.17% away from 52 week high
          • Outperformer - Kilitch Drugs (India) up by 30.4% v/s NIFTY 50 down by -3.5% in last 1 month
          Financials
          Piotroski Score
          i
          Piotroski F-Score determines the financial strength of the company and ranges between 0 to 9. Higher the score, better the financials of the company.
          4

          indicates Weak Financials

          3 year CAGR growth
          Revenue 24.5%
          NetProfit %
          OperatingProfit %
          Industry Comparison
          • TTM PE Ratio - High in industry
          • Market Cap - Below industry Median
          • Price to Book Ratio - Below industry Median
          • TTM PEG Ratio - Negative PEG TTM Price to Earnings Growth
          Shareholding Pattern
          • Promoters released all pledges in Dec 2020 qtr.
          • Promoters have decreased holdings from 68.7% to 68.63% in Dec 2020 qtr
          • Institutional Investors holding remains unchanged at 0.0% in Dec 2020 qtr

          MC Technicals

          TECHNICAL RATING
          i
          This represents current trend.
          Click here for disclaimer.
          Moving Averages Bearish
          Technical Indicators Bearish
          Moving Averages Crossovers Bearish

          Pivot levels

            R1 R2 R3 PP S1 S2 S3
          Classic - - - - - - - - - - - - - -
          Fibonacci - - - - - - - - - - - - - -
          Camarilla - - - - - - - - - - - - - -

          Note : Support and Resistance level for the day, calculated based on price range of the previous trading day.

          Pivot levels

          R1 - - Pivot
          - -
          S1 - -
          R2 - - S2 - -
          R3 - - S3 - -

          Note : Support and Resistance level for the day, calculated based on price range of the previous trading day.

          Moving Averages
          Days
          5 - -
          10 - -
          20 - -
          50 - -
          100 - -
          200 - -
          TECHNICAL RATING
          i
          This represents current trend.
          Click here for disclaimer.
          Moving Averages Bearish
          Technical Indicators Bearish
          Moving Averages Crossovers Bearish

          Pivot levels

          Type R1 R2 R3 PP S1 S2 S3
          Classic - - - - - - - - - - - - - -
          Fibonacci - - - - - - - - - - - - - -
          Camarilla - - - - - - - - - - - - - -

          Note : Support and Resistance level for the week, calculated based on price range of the previous trading week.

          Pivot levels

          R1 - - Pivot
          - -
          S1 - -
          R2 - - S2 - -
          R3 - - S3 - -

          Note : Support and Resistance level for the week, calculated based on price range of the previous trading week.

          Moving Averages
          Days
          TECHNICAL RATING
          i
          This represents current trend.
          Click here for disclaimer.
          Moving Averages Bearish
          Technical Indicators Bearish
          Moving Averages Crossovers Bearish

          Pivot levels

          Type R1 R2 R3 PP S1 S2 S3
          Classic - - - - - - - - - - - - - -
          Fibonacci - - - - - - - - - - - - - -
          Camarilla - - - - - - - - - - - - - -

          Note : Support and Resistance level for the month, calculated based on price range of the previous trading month.

          Pivot levels

          R1 - - Pivot
          - -
          S1 - -
          R2 - - S2 - -
          R3 - - S3 - -

          Note : Support and Resistance level for the month, calculated based on price range of the previous trading month.

          Moving Averages
          Days

          Price and Volume

          Price Performance
          1 Week
          --%
          1 Month
          --%
          3 Months
          --%
          YTD
          --%
          1 Year
          --%
          3 Years
          --%
          Volume Analysis

          Forum

          Community Sentiments

          Data not Available

          What's your call on today?

          Read 0 investor views

          BUY SELL HOLD

          Broker Research

          No Data For Broker Research.

          Deals

          No Data For Block Deals.
          06 Mar, 2018

          BP FINTRADE PRIVATE LIMITED

          Qty 78214 Price 96.36 % Traded 0.50
          06 Mar, 2018

          SHAH DIPAK KANAYALAL

          Qty 66699 Price 96.35 % Traded 0.43
          06 Mar, 2018

          BP FINTRADE PRIVATE LIMITED

          Qty 56811 Price 98.98 % Traded 0.37
          01 Mar, 2018

          SHAH DIPAK KANAYALAL

          Qty 80000 Price 115.88 % Traded 0.52
          27 Feb, 2018

          RONAK BANSAL

          Qty 72184 Price 122.9 % Traded 0.47
          27 Feb, 2018

          RONAK BANSAL

          Qty 72184 Price 131.28 % Traded 0.47
          22 Jan, 2018

          SUDHIR MOHANLAL JOSHI

          Qty 150410 Price 85.4 % Traded 0.97
          22 Jan, 2018

          ARUNA DINESH SHAH

          Qty 150400 Price 89.32 % Traded 0.97

          *A bulk deal is a trade where total quantity of shares bought or sold is more than 0.5% of the equity shares of a company listed on the exchange.

          Insider Transaction Summary

          Oct, 29, 2020

          Mr. Bhavin Mehta

          Promoter & Director
          Qty 103300 Price 92.5 % Traded 0.67 Post Tnx Hold. 12.94%
          Oct, 29, 2020

          Mr. Bhavin Mehta

          Promoter & Director
          Qty 103300 Price 99 % Traded 0.67 Post Tnx Hold. 12.92%
          Jul, 01, 2019

          Bhavin Mehta

          Promoter & Director
          Qty 849116 Price 0 % Traded 5.53 Post Tnx Hold. 12.99%
          Jul, 01, 2019

          Mukund Mehta

          Promoter & Director
          Qty 849116 Price 0 % Traded 5.53 Post Tnx Hold. 5.78%
          Sep, 04, 2018

          Bhavin Mehta

          Promoter & Director
          Qty 800000 Price 10 % Traded 5.21 Post Tnx Hold. 7.51%
          Sep, 04, 2018

          Neeta Mehta

          Promoter
          Qty 627000 Price 10 % Traded 4.08 Post Tnx Hold. 7.25%

          *Disclosures under SEBI Prohibition of Insider Trading Regulations, 2015

          Jul, 03, 2019

          Bhavin Mehta

          Other
          Qty 849116 Price 0 % Traded 5.47 Post Tnx Hold. 0%
          Jun, 29, 2019

          Bhavin Mehta

          Promoter
          Qty 849116 Price 0 % Traded 5.51 Post Tnx Hold. 12.99%
          Jun, 29, 2019

          Bhavin Mehta

          Promoter
          Qty 849116 Price 0 % Traded 5.51 Post Tnx Hold. 5.78%
          Jun, 20, 2019

          Bhavin Mehta

          Promoter
          Qty 849116 Price 0 % Traded 5.51 Post Tnx Hold. 0%
          Sep, 04, 2018

          Bhavin Mehta

          Promoter
          Qty 800000 Price 0 % Traded 5.21 Post Tnx Hold. 7.51%
          Sep, 04, 2018

          Mukund Mehta

          Promoter
          Qty 173000 Price 0 % Traded 1.13 Post Tnx Hold. 11.33%

          *Disclosures under SEBI SAST (Substantial Acquisition of Shares and Takeovers) Regulations, 2011

          Financials

          • Revenue
          • Net Profit
          • EPS
          • Revenue
          • Net Profit
          • EPS

          Shareholding

          PEERS

          Company Name Price % Chg MCap(Cr) TTM PE P/B ROE 1 Yr Perform Net Profit Net Sales Debt to Equity
          Kilitch Drugs 106.80 0.99 165.48 34.34 1.10 2.93 -0.14 4 60 0.08
          Sun Pharma 627.35 1.29 150522.28 58.74 3.06 8.31 35.69 4,186 32,837 0.17
          Divis Labs 3718.45 -1.62 98713.16 52.77 13.50 18.83 58.83 1,376 5,394 0.00
          Dr Reddys Labs 4777.30 -4.40 79447.09 36.52 5.09 12.98 27.51 1,969 17,517 0.11
          Cipla 885.20 -1.91 71388.13 31.91 4.46 9.81 49.31 1,546 17,131 0.18

          About the Company

          Kilitch Drugs (India) Limited is an India-based company engaged in pharmaceutical business. The Companys services range from manufacturing to marketing a host of formulations in all dosage forms, such as solid, liquid and parenteral forms. The Company is a manufacturer of antibacterial parenteral formulations. Its products include Carbapenems, Cephalosporins, Aminoglycosides, anti malarials, and other anti-infectives. The Company trades in Eyekare Pharmaceuticals products and is located in Mumbai. On February 28, 2012, the Company discontinued its manufacturing activity at Paonta Sahib. The Company also transferred certain products by entering into a product transfer agreement with Akorn India Pvt. Ltd. (AIPL) by which the right to manufacture certain products by the Company at Mumbai were sold to AIPL.
          {"success":1,"data":{"address":{"address1":"C-301\/2, M.I.D.C.,","address2":"TTC Industrial Area,,Pawane Village,","city":"New Mumbai","state":"Maharashtra","pincode":"400705","telephone1":"022-27670322","telephone2":"022-27680913","fax1":"022-27680912","fax2":"","email":"info@kilitch.com","web":"http:\/\/www.kilitch.com"},"management":[{"name":"Mukund P Mehta","designation":"Managing Director"},{"name":"Bhavin Mukund Mehta","designation":"Whole Time Director"},{"name":"Mira B Mehta","designation":"Whole Time Director"},{"name":"Hemang Engineer","designation":"Independent Director"},{"name":"Venkita Subramanian Rajan","designation":"Independent Director"}],"registrars":{"name":"Link Intime India Pvt. Ltd.","address1":"C 101, 247 Park,\nL.B.S. Marg, Vikhroli (West)","address2":"","address3":"","address4":"","telephone":"022-49186270, 49186200","fax":"022-49186060","email":"rnt.helpdesk@linkintime.co.in","internet":"http:\/\/www.linkintime.co.in","city":"Mumbai","state":"Maharashtra","pincode":"400083"},"listing":[{"name":"BSE 100","value":"No"},{"name":"BSE 200","value":"No"},{"name":"SENSEX","value":"No"},{"name":"CNX MIDCAP 200","value":"No"},{"name":"NIFTY 50","value":"No"},{"name":"BSE 500","value":"No"}],"details":{"bseId":"524500","nseId":"KILITCH","series":"EQ","isinid":"INE729D01010"}}}
          • Registered Office

            • Address

              C-301/2, M.I.D.C.,,TTC Industrial Area,,Pawane Village,

            • City

              New Mumbai

            • State

              Maharashtra

            • Pin Code

              400705

            • Tel. No.

              022-27670322

            • Fax No.

              022-27680912

            • Email

              info@kilitch.com

            • Internet

              http://www.kilitch.com

          • Registrars

          • Management

            • Mukund P Mehta

              Managing Director

            • Bhavin Mukund Mehta

              Whole Time Director

            • Mira B Mehta

              Whole Time Director

            • Hemang Engineer

              Independent Director

            • Venkita Subramanian Rajan

              Independent Director

          • Included In

            • BSE 100

              No

            • BSE 200

              No

            • SENSEX

              No

            • CNX MIDCAP 200

              No

            • NIFTY 50

              No

            • BSE 500

              No

          • Details

            • BSE:

              524500

            • NSE:

              KILITCH

            • Series

              EQ

            • ISIN

              INE729D01010

          Your feedback matters! Tell us what we got right and what we didn’t? Click here>